Applied Materials (AMAT) Q1 FY2026 Post-Earnings Debrief
1. Executive Summary
- In-line revenue, margin-driven EPS beat. Revenue of $7.01B was essentially flat to the $7.01B consensus. Non-GAAP EPS of $2.38 beat by $0.09 (+3.8%), driven by gross margin of 49.1% — 90 bps above consensus and 70 bps above the midpoint of company guidance.
- The quarter was not the story — the guide was. Q2 FY2026 guidance of $7.65B revenue / $2.64 EPS represented a +9% sequential step-up on revenue and +11% on EPS, materially above the prior Street expectation. This was the primary catalyst for the +8.1% earnings-day reaction.
- First explicit quantification of CY2026 growth: >20%. Management guided semiconductor equipment revenue to grow more than 20% in calendar 2026, second-half weighted. This was the first time AMAT provided a specific growth figure for the year and exceeded most analyst models.
- China/ICAPS upgraded from headwind to neutral. The most meaningful incremental change was the upgrade of China/ICAPS WFE from "down a little" last quarter to "flattish" — removing a key bear pillar and adding to the conviction on the >20% growth guide.
- BIS settlement clears regulatory overhang. A $252.5M accrual for the BIS export control settlement, combined with DoJ/SEC closing investigations with no enforcement actions, removes a multi-year uncertainty discount.
- 2027 visibility is building. Management described entering 2027 in a "constrained position" with multiple DRAM and leading-edge logic factories scheduled to come online — a strong forward demand signal.
- Post-earnings gains fully reversed on macro. The stock surged from $328 to $395 (52-week high on Feb 25) before the broad semi/tariff selloff erased all gains. At $325, the stock trades essentially flat to pre-earnings levels — creating a potential re-entry point given upgraded fundamentals.
- Consensus revisions confirm fundamental upgrade. FY2026 EPS estimates rose +14.0% and revenue +7.7% in the four weeks around earnings — one of the largest single-quarter revision events in the WFE peer group.
2. What Actually Mattered
Separating signal from noise in this print:
1. Q2 FY2026 guidance — HIGH importance. The $7.65B revenue guide (midpoint) was the single most important data point. It implied a +9.3% sequential acceleration and positioned the full-year trajectory well above prior Street models. Consensus Q2 EPS immediately jumped from $2.29 to $2.65 on the print.
2. >20% CY2026 semi equipment growth — HIGH importance. This was the first time management attached a specific number to annual growth expectations. Combined with "second-half weighted" commentary and the clean room constraint narrative, it provided a framework for modeling the full year and created upside risk to FY2026 consensus.
3. China/ICAPS upgrade to flat — HIGH importance. Moving from "down a little" to "flat" was incremental to estimates and removed a key bear debate. Bears had modeled ICAPS declines as an offset to AI-driven leading-edge growth; this upgrade eliminated that wedge.
4. Gross margin of 49.1%, SSG >54% — MEDIUM-HIGH importance. The non-GAAP gross margin beat of +90 bps was structurally relevant. The disclosure that Semiconductor Systems gross margin exceeded 54% was new and positions favorably for continued mix-driven margin expansion as leading-edge and DRAM grow as a share of revenue.
5. BIS settlement / regulatory clearing — MEDIUM importance. The $252.5M charge was a one-time GAAP item. The real value was the resolution itself — DoJ and SEC closing inquiries with no enforcement actions clears a years-long overhang.
6. 2027 capacity constraint commentary — MEDIUM importance. Management signaling they will enter 2027 "still in a constrained position" with multiple new factories coming online establishes the beginnings of a multi-year demand narrative, supporting duration of the cycle thesis.
7. eBeam/PDC doubling to >$1B — MEDIUM importance. This confirms a high-growth product cycle within the portfolio. At >$1B, PDC is becoming material to the segment mix and carries above-average margins.
3. Results Versus Expectations
| Metric | Reported | Company Guide (Q4 FY2025) | Consensus (Pre-Print) | Beat / Miss | Quality |
|---|---|---|---|---|---|
| Revenue | $7,012M | $6,850M ±$500M | $7,014M | -$2M (in-line) | Clean |
| Non-GAAP EPS | $2.38 | $2.18 ±$0.20 | $2.293 | +$0.087 (+3.8%) | Clean — margin driven |
| Non-GAAP Gross Margin | 49.1% | ~48.4% (midpoint) | 48.09% | +90 bps vs consensus | Durable — mix + pricing |
| SSG Revenue | $5,140M | ~$5,025M | N/A | +$115M vs guide | Clean — DRAM strength |
| AGS Revenue | $1,560M (record) | ~$1,520M | N/A | +$40M vs guide | Recurring, high quality |
| Non-GAAP OpEx | $1,340M | In line | N/A | In-line | Controlled |
| Operating Cash Flow | $1,690M | — | — | — | Solid |
| Free Cash Flow | $1,000M | — | — | — | CapEx-heavy (EPIC) |
| GAAP Diluted EPS | $2.54 | — | — | — | Includes BIS charge offset |
The EPS beat was clean and margin-driven — not tax or below-the-line. Gross margin outperformance of +90 bps versus consensus flowed directly to the bottom line. Revenue was in-line, so there was no revenue beat masking margin softness. The quality of the beat was high.
Versus Prior Guidance
Revenue at $7.01B came in at the upper end of the $6.35B–$7.35B guidance range (midpoint $6.85B). Non-GAAP EPS of $2.38 hit the top of the $1.98–$2.38 range. Gross margin of 49.1% exceeded the ~48.4% implied midpoint by 70 bps. Management sandbagged modestly on margin, which is consistent with the company's typical guidance pattern of guiding margins conservatively and delivering on the upside.
4. Historical Quarterly Comparison
| Metric | Q1 FY2026 | Q/Q % | Y/Y % | Q4 FY2025 | Q/Q % | Y/Y % | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue ($M) | $7,012 | +3.1% | -2.1% | $6,800 | -6.9% | -3.5% | $7,302 | $7,100 | $7,166 | $7,045 |
| Non-GAAP EPS | $2.38 | +9.7% | 0.0% | $2.17 | -12.5% | -6.5% | $2.48 | $2.39 | $2.38 | $2.32 |
| Gross Margin | 49.0% | +98 bps | +21 bps | 48.0% | -77 bps | +66 bps | 48.8% | 49.1% | 48.8% | 47.3% |
| GAAP Op Margin | 26.1% | +93 bps | -424 bps | 25.2% | -540 bps | -382 bps | 30.6% | 30.6% | 30.4% | 29.0% |
| EBITDA ($M) | $1,958 | +7.2% | -14.1% | $1,826 | -22.2% | -15.3% | $2,346 | $2,272 | $2,280 | $2,156 |
Q1 FY2026 represented a clean recovery from the Q4 FY2025 trough. Revenue bounced +3.1% sequentially, EPS recovered +9.7%, and gross margin returned to the 49% area. The GAAP operating margin remains compressed at 26.1% due to equity compensation, restructuring, and intangible amortization — versus the 30%+ non-GAAP operating margin range that better reflects underlying economics. Year-over-year comparisons are slightly negative on revenue (-2.1%) and flat on EPS, but this is misleading context given the Q4 FY2025 trough and the accelerating Q2 guide.
5. Guidance Bridge and Implications
| Metric | Prior Guide (for Q1) | Q1 Actual | vs Guide | New Guide (Q2 FY2026) | Sequential Δ |
|---|---|---|---|---|---|
| Revenue | $6,850M ±$500M | $7,012M | Upper end | $7,650M ±$500M | +$638M (+9.1%) |
| Non-GAAP EPS | $2.18 ±$0.20 | $2.38 | Top of range | $2.64 ±$0.20 | +$0.26 (+10.9%) |
| Non-GAAP GM | ~48.4% | 49.1% | +70 bps | ~49.3% | +20 bps |
| SSG Revenue | ~$5,025M | $5,140M | +$115M | ~$5,800M | +$660M (+12.8%) |
| AGS Revenue | ~$1,520M | $1,560M | +$40M | ~$1,600M | +$40M (+2.6%) |
| Non-GAAP OpEx | In line | $1,340M | In line | ~$1,415M | +$75M (+5.6%) |
The Q2 FY2026 guidance was the most important output of this earnings cycle. The $7.65B revenue midpoint implies a +9.1% sequential acceleration, driven almost entirely by Semiconductor Systems (+12.8% QoQ to ~$5.8B). This trajectory, if maintained and accelerated in H2 as management indicated, supports the >20% CY2026 semi equipment growth guide.
Gross margin guidance of ~49.3% for Q2 implies continued modest expansion. Management described further margin improvement as driven by portfolio mix (more leading-edge, more DRAM, more advanced packaging) partially offset by declining China mix. The OpEx step-up of +5.6% reflects EPIC center ramp costs and is expected.
Full-Year and Multi-Year Framework
- CY2026 semi equipment: >20% growth, second-half weighted. Clean room availability pacing the rate of investment.
- AGS: Low double-digit growth trajectory. Q1 tracking at +15% YoY, Q2 guided ~+13% YoY.
- ICAPS/China: Approximately flat year-over-year (upgraded from "down a little" last quarter).
- NAND: Modest growth, expected to remain less than 10% of total WFE.
- CY2027: Multiple factories (DRAM and leading-edge logic) scheduled to come online. Management expects to enter 2027 in a constrained position — a strong forward demand signal.
6. Estimate Revision Implications
| Period | Metric | Pre-Earnings (Feb 9-11) | Post-Earnings (Feb 13) | Current (Mar 4) | 4-Week Δ |
|---|---|---|---|---|---|
| Q2 FY2026 | EPS | $2.293 | $2.647 | $2.678 | +$0.385 (+16.8%) |
| Q2 FY2026 | Revenue | $7,014M | $7,612M | $7,683M | +$669M (+9.5%) |
| FY2026 | EPS | $9.752 | $10.912 | $11.115 | +$1.363 (+14.0%) |
| FY2026 | Revenue | $29,211M | $31,071M | $31,473M | +$2,262M (+7.7%) |
The magnitude of the consensus revision event is striking. FY2026 EPS rose +14.0% and revenue +7.7% in four weeks — one of the largest single-quarter consensus revisions in the WFE peer group. The revision was front-loaded (most occurred on the earnings print itself) with modest continued upward drift since.
The current consensus of $11.12 FY2026 EPS and $31.5B revenue still appears conservative given management's >20% semi equipment growth guide and the second-half weighting commentary. If H2 accelerates as guided, there is further upside to current consensus, particularly on Q3 and Q4 FY2026 estimates. FY2027 consensus of $13.88 EPS (+24.8% growth) reflects conviction that the cycle extends.
7. Transcript Intelligence
7a. Prepared Remarks
CEO Gary Dickerson's prepared remarks were built around a thesis of AI-driven semiconductor demand reaching an inflection point that accelerates the industry toward $1 trillion in revenues "several years earlier than prior predictions." The framing was deliberately bullish and forward-looking, positioning Applied Materials as the primary beneficiary across the three major vectors of leading-edge logic, DRAM/HBM, and advanced packaging.
The most notable prepared remarks disclosures included: (1) the explicit >20% CY2026 semi equipment growth quantification, (2) SSG gross margin exceeding 54% — disclosed for the first time at this specificity, (3) the Samsung EPIC co-development agreement announcement, (4) eBeam/PDC revenues doubling to more than $1 billion in CY2026, and (5) the ICAPS/China upgrade from "down a little" to "flat."
CFO Brice Hill reinforced with data points on fab utilization ("leading-edge foundry logic and DRAM capacity essentially full, prices increased"), the AGS recurring revenue model (two-thirds under contract, 2.9-year average term, 90% renewal rate), and the BIS settlement resolution.
7b. Q&A Intelligence
Management directness was notably high across the Q&A session. The most substantive exchanges:
Stacy Rasgon (Bernstein) pressed on the mathematical trajectory required to deliver >20% growth with H2 weighting. Brice Hill confirmed the math was "directionally right" and acknowledged H2 would be higher than H1, but declined to provide exact quarterly phasing — a reasonable position given clean room scheduling uncertainty.
CJ Muse (Cantor Fitzgerald) pushed on gross margin durability. Dickerson pointed to 700 bps of expansion under his tenure and said he had "very high confidence" in sustaining margin growth — unusually strong language for a management team that typically speaks in measured terms.
Mark Lipacis (Evercore ISI) asked about WFE intensity as a percentage of semiconductor revenue. Dickerson called the traditional 15% intensity framework "obsolete" and said the industry needs a "new growth framework" — a significant framing shift that, if correct, would support structurally higher WFE spending relative to semiconductor revenue.
Tim Arcuri (UBS) explored manufacturing capacity upside. Hill described "significant upside" but refused to quantify, implying SSG quarterly output could potentially exceed $10B — a number that would imply substantial upside to current consensus.
7c. Cross-Quarter Language Comparison
| Topic | Q4 FY2025 (Nov 2025) | Q1 FY2026 (Feb 2026) | Signal |
|---|---|---|---|
| China/ICAPS WFE | "down a little this calendar year" | "flattish overall, both globally and in China" | Upgrade |
| Semi equipment growth | "strong growth year, revenue weighted toward second half" | ">20% this calendar year, second-half weighted" | Explicit quantification |
| 2027 visibility | "significant production ramps coming years" | "strong growth momentum into 2027, still in constrained position entering 2027" | More explicit |
| Customer visibility | "more than one year, in some cases two years" | "significantly longer-term visibility... specific configurations better than ever" | Improving |
| DRAM fab utilization | Not highlighted | "essentially full, prices have increased" | New positive |
| Gross margin narrative | "highest level in 25 years" | Same, plus SSG >54% disclosed; "opportunity for modest improvement" | Consistent+ |
The cross-quarter language shift is uniformly positive. Every key topic saw either an upgrade or more explicit positive framing. The most important delta was the China/ICAPS upgrade — it directly addresses the primary bear concern that ICAPS normalization would offset AI-driven growth.
7d. Management Quotes — By Theme
AI Demand and Semiconductor Market
"AI is at a tipping point where improvements in performance and cost translate to real-world applications that deliver meaningful productivity gains and return on investment for users." — Gary Dickerson
"We believe that global semiconductor industry revenues can potentially reach $1 trillion in 2026, several years earlier than prior predictions." — Gary Dickerson
Semi Equipment Growth and H2 Trajectory
"For Applied, we expect to grow our semiconductor equipment business more than 20% this calendar year. We see the demand profile weighted towards the second half of the calendar year, with availability of customer clean room space being a key factor pacing the rate of investment." — Gary Dickerson
"We're signaling, 20%, greater than 20% for the calendar year. We're also signaling that the second half will be higher... we have that level of demand to signal, the 20%." — Brice Hill
Clean Room Constraint and 2027
"It's certainly metered by clean room this year, in leading edge and DRAM. And so that is putting a cap on what can be done this year... we've obviously raised our outlook for this year." — Brice Hill
"I looked at the schedule — there's a number of factories coming online in 2027 so we expect capacity to continue to be added every quarter. That will open up new opportunities for next year, and we'll go into next year with still in a constrained position." — Brice Hill
"I think it's too early to say exactly what the shape of 2027 is gonna look like. But as I said earlier, based on the customer conversations, I would expect 2027 is also gonna be a very strong year." — Gary Dickerson
DRAM and HBM Leadership
"In DRAM, customers are aggressively adding capacity at 6F² nodes... AI computing is driving significant demand for high-bandwidth memory DRAM, which has larger die sizes and requires 3x-4x more wafer starts per delivered bit than standard DRAM." — Gary Dickerson
"We've grown DRAM market share significantly over the last decade. It's our strongest business. We're going to grow share in 6F², and we're also in very strong position, and I have very high confidence that we're gonna continue to grow share in 4F²." — Gary Dickerson
Gross Margin Durability
"We made progress in gross margins, up 700 basis points since I became CEO, and we're now at the highest level in 25 years... I strongly believe we're driving the right actions to sustainably increase the value we create for customers and for Applied to share in the value we are creating." — Gary Dickerson
"I think the portfolio continues to get more valuable. Every day, we complete an R&D project, we're tuning that portfolio to the most valuable inflection. So we do think there's opportunity long term to continue to improve gross margin." — Brice Hill
AGS Recurring Revenue
"It's all recurring revenue right now. Two-thirds of it is under contract, the average contract 2.9 years, 90% renewal rate." — Brice Hill
"When we think about our dividend, we look at the cash profitability of our services business, and it can afford our dividend payment at this point." — Brice Hill
Product Pipeline and eBeam
"We expect revenues [from CFE eBeam] to double this calendar year to more than $1 billion." — Gary Dickerson
"The growth rate this year [for PDC/eBeam] is gonna be one of the fastest across all of Applied Materials, and I have very, very high confidence this growth is gonna continue at a very high rate in 2027 and going forward." — Gary Dickerson
8. Segment and KPI Forensic Review
| Segment | Q1 FY2026 Rev | Q/Q Δ | Y/Y Δ | Key Detail |
|---|---|---|---|---|
| Semiconductor Systems (SSG) | $5,140M | ~+5% | -8% | Non-GAAP GM >54% (+100 bps YoY), Op margin 32.9% (-80 bps YoY). Record DRAM revenue. |
| Applied Global Services (AGS) | $1,560M (record) | ~+3% | +15% | Non-GAAP GM +210 bps YoY, Op margin +320 bps YoY. 90% renewal rate. |
| Display & Other | ~$312M | — | — | Segment now reported as "Other" following reorg. |
Semiconductor Systems — Deep Dive
SSG at $5.14B represented 73% of total revenue and remains the primary driver of the investment thesis. The most notable development was record DRAM revenue, driven by aggressive 6F² node capacity additions and HBM demand creating a 3x-4x wafer start multiplier per delivered bit. SSG gross margin exceeding 54% was disclosed for the first time and represents a structurally important data point — it demonstrates that the leading-edge/DRAM mix shift is margin-accretive, countering the historical concern that new technology nodes compress equipment maker margins.
The Q2 guide of ~$5.8B implies +12.8% sequential growth for SSG, consistent with the acceleration narrative. The YoY decline of -8% in Q1 is backward-looking and reflects the Q1 FY2025 comp when China ICAPS was still at elevated levels.
Applied Global Services — Deep Dive
AGS hit a record $1.56B with +15% YoY growth. The segment's value proposition is increasingly important: it is entirely recurring revenue, two-thirds under long-term contract with 2.9-year average terms and 90% renewal rates. Management noted that AGS cash profitability now fully covers the dividend — framing it as a standalone cash flow engine. The 30,000+ chambers connected to the AIx monitoring platform create both stickiness and incremental productivity value for customers.
Low double-digit growth is the stated AGS trajectory, with some headwind from lost China accounts under export controls.
Key KPIs
| KPI | Q1 FY2026 | Context |
|---|---|---|
| Inventory Days | ~153 | ~$500M YoY build; intentional for EPIC and demand preparedness |
| Cash from Operations | $1,690M | Solid operating cash generation |
| Free Cash Flow | $1,000M | Suppressed by elevated CapEx for EPIC center build-out |
| Shareholder Returns | $702M | 85%+ FCF returned over trailing year (dividends + buybacks) |
| eBeam/PDC Run Rate | >$1B CY2026 (2x YoY) | Fastest-growing product line |
| AIx Connected Chambers | 30,000+ | Enables 30% faster response times |
9. Quality of the Quarter
Revenue quality: HIGH. Revenue of $7.01B came in exactly at consensus, indicating accurate Street calibration. No pull-forwards or timing benefits were called out. The recovery from the Q4 FY2025 trough was broad-based across both SSG and AGS, with record AGS and record DRAM contributing to the upside within SSG.
Margin quality: HIGH. The +90 bps gross margin beat to consensus was driven by product mix (higher leading-edge and DRAM penetration) and pricing power — both structural and durable factors. Management commentary on 700 bps of gross margin expansion under Dickerson's tenure and the SSG >54% gross margin disclosure confirm this is not a one-quarter phenomenon. No evidence of one-time margin benefits.
EPS quality: HIGH. The $0.09 EPS beat was margin-driven with no below-the-line support from tax rate or share count. OpEx was controlled and in-line with expectations. The non-GAAP tax rate of ~11% is the modeled run-rate.
Cash flow quality: MODERATE. Operating cash flow of $1.69B was solid, but FCF of $1.0B reflects elevated CapEx for the EPIC center build-out. This is investment-phase spending that should moderate once EPIC is operational (end of CY2026). The gap between OCF and FCF is investment-driven rather than a working capital or quality concern.
GAAP noise: PRESENT but one-time. The $252.5M BIS settlement accrual compressed GAAP operating margin to 26.1% versus ~29-30% non-GAAP. This is a known, one-time charge with regulatory resolution value. It does not affect run-rate earnings power.
Inventory build: INTENTIONAL. The ~$500M YoY inventory increase and ~153 days inventory reflect deliberate positioning for the H2 demand ramp and EPIC center preparation, not demand weakness. In a cycle where management is guiding >20% equipment growth with H2 weighting, inventory building is a positive signal.
10. Options and Volatility Diagnostics
| Metric | Pre-Earnings (Feb 12) | Earnings Day (Feb 13) | Current (Mar 9) |
|---|---|---|---|
| 30-Day IV | 62.90% | 52.71% | 59.83% |
| 60-Day IV | 58.04% | 52.21% | 60.73% |
| IV Crush (30d) | — | -10.19pp | — |
| IV Crush (60d) | — | -5.83pp | — |
| Put/Call OI Ratio | — | — | 1.08x |
The options market priced an implied earnings move of roughly ±7-8% (derived from pre-earnings ATM straddle pricing). The +8.1% realized move on Feb 13 was essentially at the upper end of the implied range — options were fairly priced for the event.
IV crushed sharply on the earnings print, with 30-day IV falling 10.2 percentage points from 62.9% to 52.7%. This is a standard post-earnings IV compression. However, IV has since re-expanded to 59.8% — nearly back to pre-earnings levels — driven by broad macro uncertainty (tariff anxiety, semiconductor sector rotation). Current 30-day IV sits near the 88th percentile of its recent 7-week range (48.1%–63.3%), reflecting elevated uncertainty unrelated to AMAT-specific fundamentals.
The put/call open interest ratio of 1.08x shows slightly put-skewed positioning, consistent with the broader risk-off sentiment in semiconductors rather than AMAT-specific bearishness. Short interest at 14.7M shares (1.86% of float, 1.54 days to cover) is not elevated and does not suggest meaningful short positioning.
Technical Levels
| Level | Value | Context |
|---|---|---|
| 50-Day MA | $323.18 | Current price testing as support — critical near-term level |
| 200-Day MA | $231.44 | Well below; long-term uptrend intact |
| RSI (14-day) | 41.85 | Approaching oversold (<40 threshold) |
| 52-Week High | $394.95 (Feb 25) | Post-earnings peak; now key resistance |
| 52-Week Low | $126.95 (Apr 4, 2025) | April 2025 tariff trough; +156% from low |
11. Stock Reaction Drivers
| Window | AMAT | S&P 500 | SOXX | Alpha vs SPX | Alpha vs SOXX |
|---|---|---|---|---|---|
| D0 (Feb 13) | +8.08% | +0.05% | +0.66% | +8.03pp | +7.42pp |
| D+1 (Feb 17) | +1.19% | +0.10% | -0.02% | +1.09pp | +1.21pp |
| Week+1 (Feb 20) | +5.77% | +1.07% | +1.51% | +4.70pp | +4.26pp |
| Peak (Feb 25) | +20.3% from pre | — | — | — | — |
| Current (Mar 9) | -1.1% from pre | — | — | — | — |
The initial earnings reaction (+8.1%, +8.0pp alpha vs SPX) was driven primarily by three factors in order of contribution: (1) the Q2 guidance step-up, which materially exceeded Street expectations and forced immediate upward estimate revisions; (2) the >20% CY2026 semi equipment growth quantification, which provided a clearer framework for full-year modeling; and (3) the China/ICAPS upgrade, which removed a key bear pillar.
The stock continued to rally through Feb 25, reaching a 52-week high of $394.95 (+20.3% from pre-earnings). This extended rally reflected the magnitude of consensus estimate revisions and sector-wide AI enthusiasm.
The subsequent reversal from $395 to $325 (-17.8% from peak) was driven entirely by macro factors — tariff anxiety, broader semiconductor sector de-rating, and risk-off positioning — not AMAT-specific fundamental deterioration. The result is that the stock trades at essentially the same price as pre-earnings ($325 vs $328) despite fundamentally improved estimates, creating what appears to be an asymmetric valuation setup.
12. What Mattered Less Than It Appeared
- Revenue "miss" of -$2M. The headline revenue of $7,012M versus $7,014M consensus was optically a "miss" but was immaterial — less than 0.03% variance. This was functionally in-line and did not drive the stock in either direction.
- GAAP operating margin compression. The GAAP operating margin of 26.1% versus 30%+ in recent quarters appeared concerning in isolation. It was driven by the $252.5M BIS settlement accrual and recurring non-cash items (equity compensation, intangible amortization). Non-GAAP operating margin was approximately 29-30%, consistent with the run-rate.
- Year-over-year revenue decline of -2.1%. Q1 FY2026 revenue of $7.01B was down 2.1% versus Q1 FY2025's $7.17B. This reflects the elevated China ICAPS comp from a year ago and is misleading in the context of sequential acceleration and the >20% forward growth guide.
- Elevated inventory days (~153). Inventory build of ~$500M YoY might concern quality-focused investors. However, in a cycle where management is guiding >20% growth with H2 weighting, intentional inventory building is a positive signal of demand visibility and supply chain positioning, not a warning sign.
- OpEx step-up of +5.6% in Q2 guide. The increase to ~$1.415B is EPIC center ramp spending and should be viewed as investment rather than cost discipline erosion. EPIC is expected to open end of CY2026 and generate returns through co-development partnerships (Samsung agreement announced).
- EBITDA "miss" of -$42M (-2.1%) versus consensus. The Bloomberg EBITDA consensus comparison was muddied by GAAP versus non-GAAP treatment of the BIS charge. On a clean non-GAAP basis, operating income performance was consistent with the EPS beat.
13. Post-Print Analyst Activity
| Date | Firm | Analyst | Action | PT (New) | PT (Old) | Rating |
|---|---|---|---|---|---|---|
| Feb 13 | JP Morgan | Harlan Sur | PT Raised | $400 | — | Overweight |
| Feb 13 | Barclays | Tom O'Malley | PT Raised | $450 | — | Overweight |
| Feb 13 | UBS | Timothy Arcuri | PT Raised | $430 | — | Buy |
| Feb 13 | Goldman Sachs | James Schneider | PT Raised | $390 | — | Buy |
| Feb 13 | Deutsche Bank | Melissa Weathers | PT Raised | $450 | — | Buy |
| Feb 13 | Needham | Charles Shi | PT Raised | $440 | — | Buy |
| Feb 13 | Susquehanna | Mehdi Hosseini | PT Raised | $435 | — | Positive |
| Feb 13 | Wolfe Research | Christopher Caso | PT Raised | $450 | — | Outperform |
| Feb 13 | Craig-Hallum | Christian Schwab | PT Raised | $450 | — | Buy |
| Feb 19 | Wells Fargo | Joe Quatrochi | PT Raised | $435 | — | Overweight |
| Feb 19 | TD Cowen | Krish Sankar | PT Raised | $450 | — | Buy |
| Feb 24 | Morgan Stanley | Shane Brett | PT Raised | $432 | — | Overweight |
| Feb 25 | Citi | Atif Malik | PT Raised | $420 | — | Buy |
| Feb 25 | Stifel | Brian Chin | PT Raised | $450 | — | Buy |
| Mar 1 | KeyBanc | Steve Barger | PT Raised | $450 | — | Overweight |
| Mar 5 | B. Riley | Craig Ellis | PT Raised | $450 | — | Buy |
| Mar 6 | Evercore ISI | Mark Lipacis | PT Raised | $400 | — | Outperform |
| Mar 9 | Bernstein | Qingyuan Lin | PT Raised | $425 | — | Outperform |
Consensus momentum: Unanimously positive. No post-earnings downgrades or price target cuts were observed across the 41-analyst coverage universe. Every major firm raised price targets. The consensus mean PT of $413 and median of $425 imply +27-31% upside from the current $325 level. The $450 PT cluster (Deutsche Bank, Barclays, TD Cowen, Wolfe, Craig-Hallum, KeyBanc, Stifel, B. Riley) implies +38.6% upside.
The most cautious voice is BNP Paribas (Neutral, $280 PT) — the only firm with a PT below the current stock price. New Street Research ($345, Neutral), DZ Bank ($340, Hold), and Rothschild & Co ($355, Neutral) represent the other skeptics, though even their targets are above or near the current price. Zero sell ratings across the universe.
14. Peer and Sector Read-Through
| Ticker | Price | Mkt Cap | Fwd PE | Fwd EV/EBITDA | YTD | Buy/Hold/Sell |
|---|---|---|---|---|---|---|
| AMAT | $324.74 | $257.7B | 27.1x | 22.4x | +26.4% | 34 / 7 / 0 |
| LRCX | $199.33 | $248.9B | 32.3x | 26.6x | +16.4% | 27 / 10 / 0 |
| KLAC | $1,344.55 | $176.2B | 32.4x | 26.1x | +10.7% | 18 / 11 / 2 |
| ASML | $1,292.80 | $501.8B | 37.2x | 29.6x | +20.8% | 19 / 2 / 1 |
| TER | $273.05 | $42.7B | 43.6x | 32.8x | +41.1% | 13 / 6 / 2 |
Applied Materials trades at a meaningful valuation discount to every WFE large-cap peer on forward metrics. At 27.1x forward PE, AMAT is 16-27% cheaper than Lam Research (32.3x), KLA (32.4x), and ASML (37.2x). On forward EV/EBITDA, the discount is 15-24%. The PEG ratio of 1.09x (27.1x forward PE ÷ 24.9% FY2027 EPS growth) is compelling by semiconductor standards.
The discount likely reflects: (1) AMAT's greater China revenue exposure, which creates ongoing export control headline risk even after the BIS settlement; (2) GAAP margin noise from the BIS charge and stock-based compensation that depresses reported operating margins versus peers; and (3) AMAT's broader product portfolio (deposition, etch, CMP, inspection, services) which historically commands a lower multiple than the more focused ASML (litho monopoly) or KLA (inspection/metrology leadership).
The Q1 print confirms that AMAT's fundamental trajectory (>20% equipment growth, gross margin expansion, services scaling) is at least as strong as the peer set. If the discount were to narrow by even 2-3 multiple turns on forward PE, it would imply $50-70 of additional upside from current levels.
Read-through for peers: AMAT's commentary on leading-edge foundry and DRAM capacity being "essentially full" with prices increasing is directionally positive for Lam Research (DRAM etch share leader) and KLA (metrology/inspection). The ICAPS upgrade to flat is neutral-to-positive for the group. The clean room constraint narrative supports the broader thesis that WFE spending is supply-constrained rather than demand-constrained — a favorable dynamic for the entire equipment ecosystem.
15. Investment Implications
Near-Term (Next 1-5 Trading Days)
The stock is testing the 50-day moving average ($323) with RSI approaching oversold (41.85). The macro selloff has created a divergence between the stock price (flat to pre-earnings) and fundamentals (FY2026 EPS estimates +14%). Near-term trading will be driven by broader semiconductor sentiment and tariff headlines rather than AMAT-specific factors. The stock offers a favorable risk/reward for tactical entry with a near-term floor around the 50-day MA and 27-31% upside to consensus price targets.
Next Quarter (Q2 FY2026 — reporting ~May 2026)
The Q2 guide of $7.65B / $2.64 EPS is the new bar. Management credibility is high given the Q1 guide beat. The key monitoring items are: (1) whether SSG tracks toward ~$5.8B, (2) gross margin sustaining at or above 49.3%, and (3) any incremental color on H2 phasing. If Q2 delivers in-line or better and H2 commentary remains constructive, the stock should re-rate higher as the market gains confidence in the full-year trajectory.
Medium-Term (6-12 Months)
The investment case strengthened materially with this print. The combination of >20% semi equipment growth, expanding gross margins, a clearing regulatory overhang, record services revenue, and building 2027 visibility creates a constructive fundamental backdrop. The key risk is execution on the H2 acceleration — management described this as paced by clean room availability, which introduces scheduling uncertainty but also natural demand backstop.
Thesis Assessment
This quarter increased conviction in the AMAT cycle thesis without changing its fundamental character. The bull case (multi-year AI-driven WFE upcycle with AMAT as primary beneficiary across deposition, etch, and packaging) was reinforced by the explicit >20% growth guide, the China/ICAPS upgrade, and the 2027 constraint commentary. The bear case (peak cycle risk, China regulatory escalation, valuation) was partially weakened by the BIS settlement and the ICAPS stabilization, but the tariff-driven selloff demonstrates that macro/geopolitical risk remains the primary offsetting factor.
Valuation Snapshot
| Metric | Pre-Earnings | Current (Mar 9) | Δ |
|---|---|---|---|
| Stock Price | $328.39 | $324.74 | -1.1% |
| Market Cap | ~$260.6B | $257.7B | -1.1% |
| Enterprise Value | ~$259.4B | $256.4B | -1.2% |
| FY2026 EPS Consensus | $9.752 | $11.115 | +14.0% |
| FY2026 Rev Consensus | $29.2B | $31.5B | +7.7% |
| Forward PE (FY2026) | 33.7x | 29.2x | -4.5x compression |
| Forward PE (NTM) | ~33.5x | 27.1x | -6.4x compression |
| PEG Ratio | N/A | 1.09x | — |
| Net Cash | — | $1,523M | — |
| Dividend Yield | — | 0.58% | — |
16. What to Watch Next
| Catalyst | Expected Date | Priority | What to Monitor |
|---|---|---|---|
| AMAT Master Class | Apr 8, 2026 | HIGH | Transistor and wiring technology deep-dive; potential incremental H2 color |
| Q2 FY2026 Earnings | ~May 2026 | HIGH | $7.65B revenue / $2.64 EPS bar; H2 phasing detail; Q3 guide trajectory |
| LRCX Q3 Earnings | ~Apr 2026 | HIGH | WFE demand confirmation; DRAM etch read-through; China ICAPS commentary |
| ASML Q1 Earnings | ~Apr 2026 | HIGH | EUV order momentum; clean room timing confirmation; WFE market sizing |
| US Tariff Policy Developments | Ongoing | HIGH | Semiconductor tariffs/export controls affecting China revenue and supply chains |
| EPIC Center Grand Opening | Oct 12, 2026 | MEDIUM | Investor open house at SEMICON West; EPIC facility showcase |
| Samsung Co-Development Updates | Ongoing | MEDIUM | First EPIC agreement details; potential additional customer agreements |
| HBM Demand Trajectory | Ongoing | MEDIUM | 16-hi to 20-hi+ HBM stack progression; wafer start multiplier validation |
| Gross Margin Trajectory | Quarterly | MEDIUM | Sustaining >49%; SSG >54%; mix impact from declining China % |
| AGS Growth Sustainability | Quarterly | MEDIUM | Low double-digit target; contract renewal rates; China headwind impact |
| eBeam/PDC Revenue Tracking | Quarterly | LOW | >$1B CY2026 target; 2027 growth confirmation |
| NAND Recovery Timing | Ongoing | LOW | Remains <10% of WFE; upgrades only, no wafer output increase |
Key Questions for Q2 Earnings
- Is the H2 acceleration on track? Any clean room schedule changes?
- Has the >20% growth guide moved higher (and if so, by how much)?
- Gross margin sustainability above 49% — any mix headwinds emerging?
- Are 2027 customer conversations firming into commitments?
- Incremental export control risk from any new regulatory developments?
17. Appendix — Senior Executives
Management Team (Earnings Call Participants)
| Name | Title |
|---|---|
| Gary Dickerson | President and Chief Executive Officer |
| Brice Hill | Chief Financial Officer |
| Mike Sullivan | Corporate Vice President, Investor Relations |
Covering Analysts (Q1 FY2026 Earnings Call)
| Analyst | Firm |
|---|---|
| CJ Muse | Cantor Fitzgerald |
| Krish Sankar | TD Cowen |
| Stacy Rasgon | Bernstein Research |
| Mark Lipacis | Evercore ISI |
| Timothy Arcuri | UBS |
| Vivek Arya | Bank of America Securities |
| Harlan Sur | JPMorgan Chase |
| Jim Schneider | Goldman Sachs |
| Melissa Weathers | Deutsche Bank |
| Blayne Curtis | Jefferies |
| Atif Malik | Citi |
18. Sources
Sources: Bloomberg, Applied Materials Q1 FY2026 Earnings Call Transcript (Feb 13, 2026), Applied Materials Q4 FY2025 Earnings Call Transcript (Nov 2025), Applied Materials Q1 FY2026 Earnings Press Release, Company IR Materials